These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24855239)

  • 1. Cancer immunology. Identifying the infiltrators.
    Gomez Perdiguero E; Geissmann F
    Science; 2014 May; 344(6186):801-2. PubMed ID: 24855239
    [No Abstract]   [Full Text] [Related]  

  • 2. The origin and function of tumor-associated macrophages.
    Liu Y; Cao X
    Cell Mol Immunol; 2015 Jan; 12(1):1-4. PubMed ID: 25220733
    [No Abstract]   [Full Text] [Related]  

  • 3. The cellular and molecular origin of tumor-associated macrophages.
    Franklin RA; Liao W; Sarkar A; Kim MV; Bivona MR; Liu K; Pamer EG; Li MO
    Science; 2014 May; 344(6186):921-5. PubMed ID: 24812208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical characterization and morphometric analysis of macrophages in rat mammary tumors.
    Ong CB; Brandenberger C; Kiupel M; Kariagina A; Langohr IM
    Vet Pathol; 2015 Mar; 52(2):414-8. PubMed ID: 24842486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological suppression of the occurrence of spontaneous mammary tumours in C3H/He mice.
    Irie K; Irie RF
    Nature; 1971 Sep; 233(5315):133-4. PubMed ID: 12058756
    [No Abstract]   [Full Text] [Related]  

  • 6. The human breast cancer-associated protein, the prolactin-inducible protein (PIP), regulates intracellular signaling events and cytokine production by macrophages.
    Ihedioha O; Blanchard AA; Balhara J; Okwor I; Jia P; Uzonna J; Myal Y
    Immunol Res; 2018 Apr; 66(2):245-254. PubMed ID: 29536339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid Cell COX-2 deletion reduces mammary tumor growth through enhanced cytotoxic T-lymphocyte function.
    Chen EP; Markosyan N; Connolly E; Lawson JA; Li X; Grant GR; Grosser T; FitzGerald GA; Smyth EM
    Carcinogenesis; 2014 Aug; 35(8):1788-97. PubMed ID: 24590894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annexin-A1 enhances breast cancer growth and migration by promoting alternative macrophage polarization in the tumour microenvironment.
    Moraes LA; Kar S; Foo SL; Gu T; Toh YQ; Ampomah PB; Sachaphibulkij K; Yap G; Zharkova O; Lukman HM; Fairhurst AM; Kumar AP; Lim LHK
    Sci Rep; 2017 Dec; 7(1):17925. PubMed ID: 29263330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway.
    Coscia M; Quaglino E; Iezzi M; Curcio C; Pantaleoni F; Riganti C; Holen I; Mönkkönen H; Boccadoro M; Forni G; Musiani P; Bosia A; Cavallo F; Massaia M
    J Cell Mol Med; 2010 Dec; 14(12):2803-15. PubMed ID: 19818098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 inhibition blocks M2 macrophage differentiation and suppresses metastasis in murine breast cancer model.
    Na YR; Yoon YN; Son DI; Seok SH
    PLoS One; 2013; 8(5):e63451. PubMed ID: 23667623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fucoidans Stimulate Immune Reaction and Suppress Cancer Growth.
    Vetvicka V; Vetvickova J
    Anticancer Res; 2017 Nov; 37(11):6041-6046. PubMed ID: 29061783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance and prognostic role of tumor-associated macrophages infiltration according to histologic location in canine mammary carcinomas.
    Monteiro LN; Dos Reis DC; Salgado BS; Cassali GD
    Res Vet Sci; 2021 Mar; 135():329-334. PubMed ID: 33097278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding of the immunological heterogeneity of canine mammary carcinomas to provide immunophenotypic features of circulating leukocytes as clinically relevant prognostic biomarkers.
    Estrela-Lima A; Araújo MS; da Costa-Neto JM; Ribeiro LG; Damasceno KA; D'Assis MJ; Martins-Filho OA; Teixeira-Carvalho A; Serakides R; Cassali GD
    Breast Cancer Res Treat; 2012 Feb; 131(3):751-63. PubMed ID: 21448671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate of metastasis from C3H mouse mammary tumours.
    Nias AH
    Clin Exp Metastasis; 1992 Jan; 10(1):13-7. PubMed ID: 1733642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammary tissue microenvironment determines T cell-dependent breast cancer-associated inflammation.
    Takahashi K; Nagai N; Ogura K; Tsuneyama K; Saiki I; Irimura T; Hayakawa Y
    Cancer Sci; 2015 Jul; 106(7):867-74. PubMed ID: 25940224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for T-lymphocytes in human breast cancer and in canine mammary tumors.
    Carvalho MI; Pires I; Prada J; Queiroga FL
    Biomed Res Int; 2014; 2014():130894. PubMed ID: 24672781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrosis in immune control of mammary-tumor growth.
    Vaage J
    Int J Cancer; 1992 May; 51(2):325-8. PubMed ID: 1568799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocytic infiltration and cytotoxicity under hypoxic conditions in the EMT6 mouse mammary tumor.
    Loeffler DA; Keng PC; Baggs RB; Lord EM
    Int J Cancer; 1990 Mar; 45(3):462-7. PubMed ID: 2307536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bidirectional Regulation of COX-2 Expression Between Cancer Cells and Macrophages.
    Carvalho MI; Bianchini R; Fazekas-Singer J; Herrmann I; Flickinger I; Thalhammer JG; Pires I; Jensen-Jarolim E; Queiroga FL
    Anticancer Res; 2018 May; 38(5):2811-2817. PubMed ID: 29715103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a subpopulation of macrophages in mammary tumor-bearing mice that are neither M1 nor M2 and are less differentiated.
    Torroella-Kouri M; Silvera R; Rodriguez D; Caso R; Shatry A; Opiela S; Ilkovitch D; Schwendener RA; Iragavarapu-Charyulu V; Cardentey Y; Strbo N; Lopez DM
    Cancer Res; 2009 Jun; 69(11):4800-9. PubMed ID: 19458073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.